These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4675450)

  • 41. Effects of kinins and prostaglandins on the gut.
    Bennett A
    Proc R Soc Med; 1971 Jan; 64(1):12-3. PubMed ID: 5551437
    [No Abstract]   [Full Text] [Related]  

  • 42. Bradykinin potentiating peptide PCA-Lys-Trp-Ala-Pro. An inhibitor of the pulmonary inactivation of bradykinin and conversion of angiotensin I to II.
    Stewart JM; Ferreira SH; Greene LJ
    Biochem Pharmacol; 1971 Jul; 20(7):1557-67. PubMed ID: 4355304
    [No Abstract]   [Full Text] [Related]  

  • 43. Bradykinin-potentiating activity in human serum.
    Araujo RL; Gomez MV; da Silva WD; Vieira MN
    Agents Actions; 1973 Dec; 3(5):275-7. PubMed ID: 4785025
    [No Abstract]   [Full Text] [Related]  

  • 44. [General pharmacology of aclacinomycin A (author's transl)].
    Ohmori K; Hirano S; Hori S
    Jpn J Antibiot; 1980 Feb; 33(2):192-213. PubMed ID: 6929361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological screening of some Brazilian plants.
    Barros GS; Matos FJ; Vieira JE; Sousa MP; Medeiros MC
    J Pharm Pharmacol; 1970 Feb; 22(2):116-22. PubMed ID: 4392245
    [No Abstract]   [Full Text] [Related]  

  • 46. Synthesis of bradykinin via oximinopyrazoline active esters (OPmp).
    Tomatis R; Ferroni R; Guarneri M; Benassi CA
    J Med Chem; 1973 Sep; 16(9):1053-4. PubMed ID: 4745509
    [No Abstract]   [Full Text] [Related]  

  • 47. Cholecystokinin-like activities in guinea pigs and in dogs of the C-terminal octapeptide (SQ 19,844) of cholecystokinin.
    Rubin B; Engel SL; Drungis AM; Dzelzkalns M; Grigas EO; Waugh MH; Yiacas E
    J Pharm Sci; 1969 Aug; 58(8):955-9. PubMed ID: 5344529
    [No Abstract]   [Full Text] [Related]  

  • 48. Relative activity of prostaglandins E1, A1, E2 and A2 on lipolysis, platelet aggregation, smooth muscle and the cardiovascular system.
    Weeks JR; Sekhar NC; Ducharme DW
    J Pharm Pharmacol; 1969 Feb; 21(2):103-8. PubMed ID: 4388086
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of ranatensin, a polypeptide from frog skin, on isolated smooth muscle.
    Clineschmidt BV; Geller RG; Govier WC; Pisano JJ; Tanimura T
    Br J Pharmacol; 1971 Apr; 41(4):622-8. PubMed ID: 4325450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of stretching of the guinea-pig ileum upon its response to bradykinin and to bradykinin-potentiating peptides.
    Shimuta SI; Sabia EB; Paiva AC; Paiva TB
    Adv Biosci; 1978 Jul; 17():231-6. PubMed ID: 755698
    [No Abstract]   [Full Text] [Related]  

  • 51. The biological and pharmacological properties of some fibrinogen degradation products.
    Malofiejew M
    Scand J Haematol Suppl; 1971; 13():303-10. PubMed ID: 4333881
    [No Abstract]   [Full Text] [Related]  

  • 52. Histamine, 5-hydroxytryptamine, kinins and the anti-inflammatory activity of human plasma fraction in carrageenan-induced paw oedema in the rat.
    Bolam JP; Elliott PN; Ford-Hutchinson AW; Smith MJ
    J Pharm Pharmacol; 1974 Jun; 26(6):434-40. PubMed ID: 4154988
    [No Abstract]   [Full Text] [Related]  

  • 53. Occurrence of a kinin-like peptide in the urinary bladder of the toad Bufo marimus paracnemis Lutz.
    Furtado MR
    Biochem Pharmacol; 1972 Jan; 21(1):118-24. PubMed ID: 4621713
    [No Abstract]   [Full Text] [Related]  

  • 54. A study of some bradykinin potentiating peptides derived from plasma proteins.
    Faber DB; Van der Meer C
    Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):226-43. PubMed ID: 4358297
    [No Abstract]   [Full Text] [Related]  

  • 55. Bradykinin-potentiating peptides from the venom of Agkistrodon halys blomhoffi. Isolation of five bradykinin potentiators and the amino acid sequences of two of them, potentiators B and C.
    Kato H; Suzuki T
    Biochemistry; 1971 Mar; 10(6):972-80. PubMed ID: 4323853
    [No Abstract]   [Full Text] [Related]  

  • 56. Assay of kinins by their effects on blood pressure.
    Roblero J; Ryan JW; Stewart JM
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):206-12. PubMed ID: 4733998
    [No Abstract]   [Full Text] [Related]  

  • 57. The response of the rat duodenum to bradykinin.
    Montgomery EH
    Proc West Pharmacol Soc; 1968; 11():51-2. PubMed ID: 5734484
    [No Abstract]   [Full Text] [Related]  

  • 58. [On the biological properties of some fibrinogen degradation products (FDP)].
    Malofiejew M
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst Suppl; 1968; 23():1-65. PubMed ID: 4310706
    [No Abstract]   [Full Text] [Related]  

  • 59. Cyclic analogue of bradykinin possessing selective and prolonged biological activity.
    Chipens GI; Mutulis FK; Katayev BS; Klusha VE; Misina IP; Myshlyiakova NV
    Int J Pept Protein Res; 1981 Sep; 18(3):302-11. PubMed ID: 7341523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 6-glycine-8-phenyllactic acid bradykinin. Its synthesis, biological activity, and splitting by kininase (carboxypeptidase N).
    Ravdel GA; Filatova MP; Shchukina LA; Paskhina TS; Surovikina MS; Trapeznikova SS; Egorova TP
    J Med Chem; 1967 Mar; 10(2):242-6. PubMed ID: 6034068
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.